Abstract
The biological properties of the lanthanides, primarily based on their similarity to calcium, have been the basis for research into potential therapeutic applications of lanthanides since the early part of the twentieth century. Up to date, cerium nitrate has been used as a topical cream with silver sulfadiazene for the treatment of burn wounds. A lanthanide texaphyrin complex (motexafin gadolinium) has been evaluated through Phase III clinical trials for the treatment of brain metastases in non-small cell lung cancer. Lanthanum carbonate (Fosrenol) as a phosphate binder has been approved for the treatment of hyperphosphatemia in renal dialysis patients in both the USA and Europe. This review will highlight therapeutic applications of the lanthanides for burn wounds, cancer, hyperphosphatemia, immune function, magnetic resonance imaging (MRI) contrast agents and osteoporosis, and discuss their future potential in the medical fields.
Keywords: Lanthanides, therapeutic application, burn wounds, cancer, hyperphosphatemia, immune function, MRI contrast agents, osteoporosis, Diagnostic Applications, magnetic resonance imaging, Lanthanum carbonate, texaphyrin complex, motexafin gadolinium
Mini-Reviews in Medicinal Chemistry
Title: Recent Progress in Therapeutic and Diagnostic Applications of Lanthanides
Volume: 11 Issue: 8
Author(s): J. Zhang, Y. Li, X. Hao, Q. Zhang, K. Yang, L. Li, L. Ma, S. Wang and X. Li
Affiliation:
Keywords: Lanthanides, therapeutic application, burn wounds, cancer, hyperphosphatemia, immune function, MRI contrast agents, osteoporosis, Diagnostic Applications, magnetic resonance imaging, Lanthanum carbonate, texaphyrin complex, motexafin gadolinium
Abstract: The biological properties of the lanthanides, primarily based on their similarity to calcium, have been the basis for research into potential therapeutic applications of lanthanides since the early part of the twentieth century. Up to date, cerium nitrate has been used as a topical cream with silver sulfadiazene for the treatment of burn wounds. A lanthanide texaphyrin complex (motexafin gadolinium) has been evaluated through Phase III clinical trials for the treatment of brain metastases in non-small cell lung cancer. Lanthanum carbonate (Fosrenol) as a phosphate binder has been approved for the treatment of hyperphosphatemia in renal dialysis patients in both the USA and Europe. This review will highlight therapeutic applications of the lanthanides for burn wounds, cancer, hyperphosphatemia, immune function, magnetic resonance imaging (MRI) contrast agents and osteoporosis, and discuss their future potential in the medical fields.
Export Options
About this article
Cite this article as:
Zhang J., Li Y., Hao X., Zhang Q., Yang K., Li L., Ma L., Wang S. and Li X., Recent Progress in Therapeutic and Diagnostic Applications of Lanthanides, Mini-Reviews in Medicinal Chemistry 2011; 11 (8) . https://dx.doi.org/10.2174/138955711796268804
DOI https://dx.doi.org/10.2174/138955711796268804 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Therapeutic Applications of Exosomes in Different Types of Diseases: A Review
Current Molecular Medicine Viruses in Semen and Male Genital Tissues - Consequences for the Reproductive System and Therapeutic Perspectives
Current Pharmaceutical Design Defensin Participation in Innate and Adaptive Immunity
Current Pharmaceutical Design Inhaled Dry Powder Formulations for Treating Tuberculosis
Current Drug Delivery Combinatorial Protein Biochemistry for Therapeutics and Proteomics
Current Pharmaceutical Biotechnology Recent Therapeutic Advances for Treating Medulloblastoma: Focus on New Molecular Targets
CNS & Neurological Disorders - Drug Targets Huntingtons Disease: New Frontiers for Molecular and Cell Therapy
Current Drug Targets CXCL12-CXCR4 Axis in Angiogenesis, Metastasis and Stem Cell Mobilization
Current Pharmaceutical Design The Diterpenoids of the Genus Elaeoselinum (Apiaceae) and their Biological Properties
Current Organic Chemistry Vitamin D Deficiency and Acute Lung Injury
Inflammation & Allergy - Drug Targets (Discontinued) Bcl-2 Proteins: Targets and Tools for Chemosensitisation of Tumor Cells
Current Medicinal Chemistry - Anti-Cancer Agents SNP Analysis Combined with Protein Structure Prediction Defines Structure- Functional Relationships in Cancer Related Cytochrome P450 Estrogen Metabolism
Current Medicinal Chemistry Synthesis and Biological Evaluation of Novel Osthol Derivatives as Potent Cytotoxic Agents
Medicinal Chemistry Nutrition and NSCLC; Should We Administer Food Supplements?
Current Pharmaceutical Design Sentinel Node Imaging
Current Medical Imaging Novel Analogues of CC-1065 and the Duocarmycins for the Use in Targeted Tumour Therapies
Anti-Cancer Agents in Medicinal Chemistry Phosphorothioate Oligonucleotides: Effectiveness and Toxicity
Current Drug Targets Genetics of Chronic Obstructive Pulmonary Disease
Current Respiratory Medicine Reviews Editorial
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) PI3K/Akt Signalling Pathway Specific Inhibitors: A Novel Strategy to Sensitize Cancer Cells to Anti-Cancer Drugs
Current Pharmaceutical Design